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Abstract
Background: The 'closing-in' phenomenon is defined as a tendency to close in on a model while
copying it. This is one of several constructional apraxia observed in dementia, particularly in
Alzheimer's disease (AD). The aim of this study was to investigate the usefulness of it in the
differential diagnosis of AD and subcortical vascular dementia (SVD) and to clarify the factors
associated with it.
Methods: We operationally defined and classified it into three types, namely overlap, adherent,
and near type. We analyzed the incidence of it in patients with AD (n = 98) and SVD (n = 48).
Results: AD patients exhibited a significantly higher occurrence of it as compared to SVD patients.
Among the different types of it, the overlap and adherent types occurred almost exclusively in AD
patients. A discriminant analysis in AD subjects revealed that the scores obtained from the MMSE,
CDR, Barthel index, and the Rey-Osterrieth complex figure test were correlated significantly with
the occurrence of it. There was no statistical difference between the Q-EEG parameters of patients
that exhibited the closing-in phenomenon and those that did not.
Conclusions: This study suggests that the closing-in phenomenon is phase- and AD-specific and
might be a useful tool for the differential diagnosis of AD and SVD.
Background
Alzheimer's disease (AD) and vascular dementia (VD) are
the most common causes of dementia. Accurate differen-
tial diagnosis is essential to initiate appropriate treatment
and to provide information about the prognosis and fac-
tors that may affect the course of the illness [1-4]. How-
ever, VD is not a single illness; it is comprised of dementia
due to large artery stroke, subcortical vascular (or small
vessel) dementia (SVD), and other less frequently
observed vascular lesions [5].
SVD affects the white matter and basal ganglia bilaterally
and diffusely. It can lead to dementia that is characterized
by impairment of behaviors, such as executive function-
ing, goal formation, initiation, planning, organizing, self
maintenance, sequencing, and abstraction [6]. Whereas
the cognitive impairments that follow a stroke tend to
recede over time, SVD is often progressive and can be con-
fused with AD. Stepwise deterioration and focal symp-
toms are not always symptoms of SVD [7]. Many previous
neuropsychological studies comparing AD and VD have
included multi-infarct patients or mixed groups of multi-
infarct/SVD patients. Such heterogeneity in the definition
of vascular dementia has contributed to conflicting neu-
ropsychological test results in the differential diagnosis of
dementia.
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Although previous studies have revealed many aspects of
the pathophysiology of AD, no specific biological markers
for this disease have yet been detected. Therefore, the diag-
nosis of AD is primarily clinical and the disease cannot be
diagnosed on the basis of laboratory findings alone.
Moreover, diagnostic accuracy is lower in the early stages
of AD, when the disease is often confused with other
forms of dementia, particularly SVD [8,9]. The low level of
diagnostic accuracy has stimulated a search for in vivo
markers of AD, such as apolipoprotein E, that can be used
to better differentiate AD from other forms of dementia.
However, none of the putative markers currently available
show sufficient sensitivity or specificity. The lack of a gen-
erally acceptable in vivo marker for diagnosis of AD and
the paramount importance of cognitive and behavioral
symptoms in the clinical diagnosis of this disease have
prompted some researchers to use neuropsychological
methods to improve the discrimination of AD from other
forms of dementia.
The abnormal behavioral patterns often observed in
demented patients during the execution of visual-spatial
tasks might be useful in differentiating AD from vascular
forms of dementia. In 1935, Mayer Gross described the
closing-in phenomenon, which is a tendency to close in
on a model while performing a constructive task [10]. It is
not clear whether the underlying pathophysiolgy is one
manifestation of a larger disturbance, best interpreted as a
difficulty in making an abstract copy from a concrete
model through symbolization, or is simply a reflection of
visuospatial dysfunction, but this unique phenomenon is
recognized as one of the constructional apraxias often
associated with AD. However, the contribution of the
closing-in phenomenon to the differential diagnosis of
dementia has remained uncertain, and the potential use
of this test in diagnosing AD has not been explored in
detail.
From a practical standpoint, investigations of the closing-
in phenomenon are faced with the initial problem of
clearly defining it, because there is a great deal of variety
in the behavioral operations that are subsumed under the
concept of the closing-in phenomenon. For example,
Mayer Gross described a series of behaviors that were
observed "in writing, drawing, in imitating finger pos-
tures, in copying mosaics"; these behaviors were collec-
tively referred to as 'closing-in.' In the present study, we
considered symptoms associated with the graphic aspect
of the closing-in phenomenon, i.e., symptoms observed
in subjects performing a graphic copying task. We defined
the closing-in phenomenon as the tendency of a subject to
make a copy of a model shape as close as possible to, or
even within, the original as compared to younger control
subjects.
The main purpose of this study was to perform a system-
atic comparison of the incidence and qualitative aspects
of the closing-in phenomenon in AD and SVD patients
(using current classifications of SVD and AD), and to eval-
uate the clinical value of this phenomenon in the differen-
tial diagnosis of AD and SVD.
Methods
Study population
The study was conducted between November 1998 and
January 2003. Patients eligible for this study had a diagno-
sis of uncomplicated AD (n = 98) or SVD (n = 48). Two
control groups of younger (n = 30) and older (n = 22) sub-
jects without symptoms of dementia were enrolled. The
diagnosis of AD was based on the criteria established by
the National Institute of Neurological and Communica-
tive Disorders and the Alzheimer's Disease and Related
Disorders Association (NINCDS-ADRDA) [11]. SVD was
diagnosed according to the criteria outlined by Erkinjuntti
et al. (2000)[12]. AD and SVD patients also had to satisfy
the criteria for dementia set out in the fourth edition of
the Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV). Patients had mini-mental state examination
(MMSE) [13] scores between 6 and 25 and a clinical
dementia rating (CDR) of 1 (mild dementia), 2 (moder-
ate), or 3 (severe) [14]. Patients who had been taking
cholinesterase inhibitors within one month of the com-
mencement of the study were not included.
The following scales were quantified: the Barthel index
[15], a scale for the activity of daily living; the geriatric
depression scale (GDS) [16], a scale for depression; and
the copying of the Rey-Osterrieth complex figure test
(ROCFT) [17,18], a scale for constructional ability.
Demographic characteristics did not differ between AD
and SVD patients. The mean ages for the AD and SVD
groups were 76.92 and 76.75 years old, respectively. The
mean CDR score, which reflects the severity of dementia,
was not different between the AD and SVD patients (Table
1). In the AD group, the MMSE score and GDS were both
significantly lower than in the SVD group, whereas the
Barthel index was significantly higher in SVD than in AD
patients (Table 1).
To exclude disorders other than AD and SVD, all patients
underwent a full neurological examination, standard
diagnostic laboratory tests, a neuropsychological investi-
gation, and an MRI brain scan. In addition, quantitative
electroencephalography (Q-EEG) was carried out to inves-
tigate electrophysiological changes in patients who exhib-
ited the closing-in phenomenon.BMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/3
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Definition of the closing-in phenomenon
Though the closing-in phenomenon is also found ROCFT
and MMSE double pentagon, the operational definition is
very difficult, so the "Alternating Square and Triangle"
task [19], simple and easy test to define this phenomenon,
was chosen for operational definition. To define the clos-
ing-in phenomenon, the younger controls carried out a
behavioral task in which they were required to copy
shapes. A subject was asked by an examiner to draw a copy
of a model shape below the original on A4 paper (Fig. 1),
but was not provided with a suggested starting point. After
completing this task, the distance between the starting
and ending points between the original and copied shapes
was analyzed statistically. Based on these observations, an
analytical study allowed us to distinguish the following
three different types of closing-in phenomena: (1) Over-
lap type – a tendency to overlap the lines of the model
with the copy; (2) Adherent type – a tendency to make
copies very close to, or adherent with, the model (differ-
ence > 3 standard deviations, as compared to copies made
by younger controls; adherent type); (3) Near type – a ten-
dency for the copy end point to be located close to the
original model (distance between the starting point of the
copy and the end point of the original model shape > 3
standard deviations, as compared to younger controls)
(Fig. 2).
Spectral parameter analysis of Q-EEG
EEGs were carried out in a quiet room under continuous
supervision. The conscious subjects were seated in a com-
fortable chair with their eyes closed. EEG traces were
recorded from 20 electrodes located according to the 10–
20 international system, with reference to linked mas-
toids, and stored on a computer (α-trace digital EEG, Best)
for conventional visual inspection. The EEG was band
pass-filtered at 1–64 Hz prior to digitizing, with a sam-
pling rate of 128 Hz and a notch filter in each channel.
Data were reviewed off-line. Fifteen 2-s epochs that were
free of artifacts were selected for further processing. A
spectral density function W (f) was calculated using fast
Fourier transformation (FFT) [20]. The localized field
power, which corresponds to the localized EEG amplitude
(absolute and relative EEG power), was calculated for the
following four frequency bands: 1–4 Hz (delta), 4–8 Hz
(theta), 8–13 Hz (alpha) and 13–30 Hz (beta).
Final data values were normalized by logarithmic trans-
formation. The locations of the generators for each fre-
quency band were determined for the anterior (averaging
Table 1: General characteristics of patients(mean ± standard deviation)
Groups Younger controls (N = 30) Elderly controls (N = 22) Alzheimer's disease (N = 98) Small Vessel Dementia (N = 48) P-value*
Sex (M : F) 8:22 14 : 8 33 : 65 22 : 26 NS
Age 29.48 ± 5.90 67.30 ± 8.46 76.92 ± 8.03 76.75 ± 5.87 NS
Age of onset - - 73.27 ± 11.79 72.28 ± 12.61 NS
Duration - - 33.10 ± 23.10 26.30 ± 27.19 NS
Education 14.57 ± 0.98 10.43 ± 6.58 6.46 ± 5.47 6.96 ± 4.89 NS
MMSE 29.10 ± 1.21 28.12 ± 1.64 14.58 ± 5.67 16.58 ± 5.04 0.03
Barthel index 19.81 ± 0.21 19.11 ± 1.21 17.46 ± 4.53 11.26 ± 6.74 0.00
CDR - - 1.76 ± 0.76 1.77 ± 0.71 NS
GDS - - 16.37 ± 7.50 20.94 ± 4.97 0.04
*Statistical significance was tested between Alzheimer disease and Vascular dementia MMSE; Mini-Mental State Examination GDS; Geriatric 
Depression Scale CDR; Clinical Dementia Rating Scale
Examples of subtypes of "closing-in" are shown, (A) near  type (B) adherent type, (C) overlap type Figure 2
Examples of subtypes of "closing-in" are shown, (A) near 
type (B) adherent type, (C) overlap type.BMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/3
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power of F3, F4, F7, F8 leads), centrotemporal (averaging
power of T4, C4 and T3, C3 leads), and posterior (averag-
ing power of T6, P4, O2 and T5, P3, O1 leads)
dimensions.
Diagnostic value and analysis of factors associated with 
the closing-in phenomenon
Based on our definition, the incidence of the closing-in
phenomenon was obtained for each study group. The sen-
sitivity and specificity of using closing-in for the differen-
tial diagnosis of AD and SVD were calculated. Finally, the
factors associated with the closing-in phenomenon were
analyzed in AD patients.
Statistical analysis
For statistical analyses, we used Student's t-test, the Chi-
square test, one-way ANOVA, and discriminant analysis
(SPSS ver. 8.0). Statistical significance was defined as p <
0.05.
Results
Incidence of the closing-in phenomenon
Although some patients were unable to complete the
drawing task (deformed drawing group), the incidence of
the closing-in phenomenon was significantly higher in
the AD group than in the SVD group (p = 0.043). With the
exception of one patient, the overlap and adherent type of
closing-in were observed exclusively in AD patients. The
sensitivity and specificity of the closing-in phenomenon
in the AD groups were 51.9% (41/79 patients) and 71.1%
(27/38), respectively (Table 2). The closing-in phenome-
non occurred mostly in patients with dementia, but was
not confined to the AD and SVD groups. For example, two
of the elderly controls (subjects without dementia) exhib-
The "Alternating Square and Triangle" task in A4 paper Figure 1
The "Alternating Square and Triangle" task in A4 paper
Table 2: Frequency of "closing-in" phenomenon among study groups.
Groups Younger controls (N = 30) Elderly control (N = 22) Alzheimer's Disease* (N = 98) Small Vessel Dementia* (N = 48)
Closing-in(-) 30 20 38 27
Closing-in(+)
Overlap 0 0 7 1
Adherent 0 0 5 0
Near 0 2 29 10
Deformed drawing 0 0 19 10
*Statistical significance was found between Alzheimer's disease and Small Vessel dementia(p-value; 0.043)BMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/3
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ited the near type of closing-in phenomenon (9.1%, 2/
22).
The associated factors of the closing-in phenomenon in AD 
patients
To clarify the factors associated with the closing-in phe-
nomenon in AD patients, discriminant analysis was car-
ried out. The MMSE score, Barthel index, CDR score, and
ROCFT score were each found to be correlated signifi-
cantly with the occurrence of the closing-in phenomenon.
Other factors, including sex, education level, early onset,
and GDS score were unrelated to the incidence of the clos-
ing-in phenomenon (Table 3).
Differences in the Q-EEG field power among AD patients
To quantify differences in the field power of AD associated
with the closing-in phenomenon, Q-EEG data were
recorded and analyzed. The delta spectral power tended to
increase relative to the theta spectral power and decrease
relative to the alpha and beta spectral powers in AD
patients who exhibited the closing-in phenomenon, as
compared to those AD patients that did not. However,
none of these differences was statistically significant. The
relative alpha spectral power was significantly lower in the
deformed drawing group than in the other groups (Table
4).
Discussion
Objects and patterns in space are interpreted according to
the laws of perspective using higher cortical association
systems. Thus, human behavior is influenced by spatial
interpretation and lesions within the cortical systems that
regulate such behavior lead to a disruption of spatial inter-
pretation. Disruption of spatial interpretation is fre-
quently observed in patients with AD and, therefore,
understanding this phenomenon is important for under-
standing the clinical expression of dementia. In this
regard, the closing-in phenomenon is particularly relevant
for diagnostic purposes, because it is thought to be a dys-
function that is peculiar to AD.
The cause and anatomical origin of the closing-in phe-
nomenon, and why this phenomenon is observed
frequently in AD patients, are unclear. Mayer Gross
stressed the value of this phenomenon as importantly
supporting his interpretation of constructional apraxia,
which he defined as a reduction in the optimal use of the
hands in tasks carried out in "active space"; he also spoke
of a fear of "empty space" [10]. Although a precise diagno-
sis of the patients examined by Gross cannot be made, all
of the patients exhibited apraxia and three had focal neu-
rological symptoms. Most of the patients in whom the
closing-in phenomenon was observed also had dementia.
Gross suggested that patients find it increasingly difficulty
to copy a model as cognitive dysfunction progresses. To
cope with this problem, the patient tends to make copies
that are very close or adherent to the model. If dementia
is well advanced, the copy may overlap the model. Gross
proposed that this phenomenon reflects the patient's fear
of empty space. The closing-in phenomenon is potentially
useful as a clinical tool for diagnosing AD; it is particularly
valuable because it is straightforward, as compared to
other tests that are used for the diagnosis of AD such as
memory tests and assessments of other aspects of demen-
tia. In addition, it has been demonstrated that the closing-
Table 3: Clinical differences between Alzheimer patients with "closing-in" and without "closing-in" phenomenon (mean ± standard 
deviation).
Variables Closing-in(-) (N = 38) Closing-in(+) (N = 41) Deformed (N = 19) p-value*
Sex Male 12 15 6 0.875
Female 26 26 13
Education(year) 8.20 ± 5.17 7.39 ± 5.13 6.89 ± 5.35 0.240
Age at onset ≤ 65 7 9 6 0.322
> 6 5 3 13 21 3
Apolipoprotein E 4 ≥ 14 4 5 0 . 8 2 7
E 4 < 1 10 13 10
Symptom duration (month) 31.2 ± 23.4 30.8 ± 23.0 42.4 ± 21.9 0.202
MMSE** 17.31 ± 5.03 14.83 ± 5.07 8.89 ± 3.80 0.000
GDS 15.64 ± 7.17 17.62 ± 7.67 13.85 ± 8.17 0.378
Barthel index*** 18.38 ± 4.42 17.89 ± 3.57 14.37 ± 5.66 0.008
CDR*** 1.49 ± 0.70 1.68 ± 0.70 2.42 ± 0.61 0.000
ROCFT** 18.13 ± 9.40 9.56 ± 9.01 1.90 ± 1.71 0.000
* Statistical test was done by discriminant function analysis ** Statistical significance was found among study groups ***Statistical significance was 
found between patients with "closing-in" and deformed. MMSE; Korean Mini-Mental State Examination GDS; geriatric depression scale CDR; clinical 
dementia rating scale ROCFT; Rey-Osterrieth Complex Figure Test Apoprotein E allele was not checked in all cases.BMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/3
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in phenomenon constitutes a useful tool for making a dif-
ferential diagnosis of AD, as it has low sensitivity (30%)
and high specificity (97.5%) for AD [21,22]. Moreover,
the closing-in phenomenon is more sensitive in detecting
advanced as compared to mild AD [23].
In the present study, the closing-in phenomenon associ-
ated with AD did not have high sensitivity (51.9%, 41/
79), suggesting that this phenomenon might be of limited
value for the diagnosis of AD. However, this was contra-
dicted by the observation that the closing-in phenome-
non had high specificity (71.1%, 27/38), which suggests
that this test might be useful for differential diagnosis
between AD and SVD. A detailed analytical study of the
closing-in phenomenon revealed that the near type was
found not only in patients with dementia, but also in sub-
jects without dementia. Nevertheless, overlap and the
adherent type of closing-in phenomenon were found
almost exclusively in AD patients (Table 2).
Although the closing-in phenomenon is regarded as a
pathological symptom of AD that is not detected in eld-
erly control subjects [22], we hypothesize that aging
might be associated with an increase in the incidence of
the closing-in phenomenon. This assertion is based on a
comparison of data between elderly and younger control
subjects (< 40 years old). Our results demonstrated that
although the incidence is low (9.1%, 2/22), the near type
of closing-in phenomenon occurs in some elderly subjects
who do not exhibit any signs of dementia. This result con-
firms our hypothesis that the closing-in phenomenon is
not only a pathological symptom of AD, but is also a
physiological phenomenon that is related to the aging
process. The main reason for the discrepancy between our
results and those of previous studies may lie in differences
between the experimental paradigms (the behavioral
task), and in the definition and classification of the
closing-in phenomenon. It is also possible that this dis-
crepancy arose because the elderly control subjects exam-
ined in the present study were older than those included
in the previous study (67.3 vs. 62.9 years) [22].
Interestingly, 2- to 3-year-old children exhibit a marked
tendency towards the closing-in phenomenon, which
decreases progressively with age, eventually becoming
irrelevant after six years of age [23]. Therefore, in the vari-
ous dissolution stages of dementia, the closing-in
phenomenon might represent the re-emergence of a prim-
itive 'magnetic reaction' pattern, much like the grasping
pattern, sucking reflex, echolalia, and echopraxia, which
are all functions supported by a neurological apparatus
that is built in from birth [24,25]. These primitive forms
of behavior, which are characterized by reflex actions that
are prompt and regular, would seem to be a necessary
preface to corresponding types of learning. In advanced
dementia, these behaviors re-emerge, as the higher corti-
cal centers become increasingly unable to inhibit such
reflex behavior patterns [23]. Although such behavior pat-
terns in children and demented adults are not identical,
these findings suggest that evolutionary and dissolution
behavior patterns might be similar [26].
Although the closing-in phenomenon has been well char-
acterized as a physiological or pathological phenomenon
that is closely related to age, the anatomical localization
of this phenomenon is not yet certain. The observation
that the closing-in phenomenon is more common in AD
than in SVD patients suggests that anatomical localization
is not confined to a prefrontal circuit (which is the pri-
mary anatomical lesion in SVD), but is instead more
widespread. To clarify the factors that are associated with
the closing-in phenomenon in AD, discriminant analysis
Table 4: Relative spectral power of qEEG in Alzheimer disease with "closing-in" and without "closing-in" phenomenon.
Closing-in(-) (N = 38) Closing-in(+) (N = 41) Deformed (N = 19) p-value*
Anterior field Delta 1.00 ± 0.13 1.09 ± 0.16 1.05 ± 0.13 0.446
Theta 1.09 ± 0.12 1.11 ± 0.17 1.14 ± 0.13 0.591
Alpha** 1.13 ± 0.12 1.10 ± 0.08 1.01 ± 0.08 0.009
Beta 1.38 ± 0.08 1.36 ± 0.08 1.34 ± 0.07 0.317
Centrotemporal field Delta 0.95 ± 0.14 1.00 ± 0.17 1.01 ± 0.13 0.489
Theta 1.09 ± 0.13 1.11 ± 0.16 1.13 ± 0.13 0.672
Alpha** 1.15 ± 0.12 1.12 ± 0.09 1.01 ± 0.08 0.004
Beta 1.38 ± 0.07 1.36 ± 0.08 1.01 ± 0.08 0.545
Posterior field Delta 0.94 ± 0.14 0.98 ± 0.18 1.01 ± 0.14 0.446
Theta 1.10 ± 0.13 1.13 ± 0.15 1.14 ± 0.13 0.636
Alpha** 1.20 ± 0.13 1.18 ± 0.12 1.03 ± 0.09 0.001
Beta 1.37 ± 0.07 1.35 ± 0.08 1.34 ± 0.07 0.679
* One-way ANOVA test ** Statistical significance was found between deformed and other groups.BMC Neurology 2004, 4 http://www.biomedcentral.com/1471-2377/4/3
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was carried out; the results indicated that the MMSE score,
Barthel index, CDR score, and the copying of ROCFT are
significantly related with the closing-in phenomenon. As
most of these factors do not provide a definitive anatom-
ical localization but, rather, characterize a particular stage
of the disease, their value for understanding anatomical
pathology is limited. However, the copying of the ROCFT
test, which requires visual memory, planning, and organ-
izational skills, reflects the comprehensive function of the
frontal and parietal lobes [27]. Therefore, the close associ-
ation between the closing-in phenomenon and the
ROCFT test suggests the involvement of these widespread
anatomical locations.
The relative alpha spectral Q-EEG power was significantly
lower in the deformed drawing group than in the other
groups, in all fields. However, there were no significant
changes in spectral power between groups that did and
did not exhibit the closing-in phenomenon. Therefore,
the Q-EEG data do not suggest any anatomical localiza-
tion for the closing-in phenomenon.
In conclusion, the results of the present study indicate that
the closing-in phenomenon is valuable in the differential
diagnosis of AD. In addition, although this phenomenon
is disease-specific, it is also a phase-specific marker that is
predominant in moderately advanced dementia (Table
3). Anatomical localization of this phenomenon is uncer-
tain, but might be related to widespread brain regions.
Although they were not assessed precisely for the limited
number of cases in the present study, the overlap and
adherent subtypes of the closing-in phenomenon
occurred almost exclusively in AD patients. Therefore, if
these subclasses are included, the closing-in phenomenon
is both a specific and sensitive tool for the differential
diagnosis of AD and SVD, suggesting that further clinical
study might yield promising results.
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